Company Search:
Advanced Search
Sponsored Links
CanniMed Therapeutics Inc Company Snapshot
CanniMed Therapeutics Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares CanniMed Therapeutics Inc with three other pharmaceutical manufacturers in North America: Editas Medicine Inc of the United States (2017 sales of $13.73 million of which 100% was Pharmaceutical), Vical Incorporated of the United States ($13.82 million of which 100% was Biopharmaceutical), and Acceleron Pharma Inc which is also based in the United States ($13.48 million of which 100% was Bio-pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
CanniMed Therapeutics Inc
  Stock Performance Chart for CanniMed Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 32.80
(Figures in Canadian Dollars)
1 Week 2.8%   13 Weeks -7.2%  
4 Weeks -5.7%   52 Weeks 179.1%  
CanniMed Therapeutics Inc Key Data:
  Ticker: CMED Country: Canada
  Exchanges: TOR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 16,687,000
(Year Ending Jan 2018).
Employees: 204
  Currency: Canadian Dollars Market Cap: 812,018,284
  Fiscal Yr Ends: October Shares Outstanding: 24,756,655
  Share Type: Common Closely Held Shares: 8,104,047
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.